TITLE

Superficial vein thrombosis associated with higher risk for DVT in lower extremities

AUTHOR(S)
Adams, Stacey L.; Harris, Jason; Haigh, Christen
PUB. DATE
August 2009
SOURCE
Hem/Onc Today;8/25/2009, Vol. 10 Issue 16, p25
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
This article deals with a study examined the association between superficial vein thrombosis and risk for deep vein thrombosis in the lower leg.
ACCESSION #
43942690

 

Related Articles

  • EL INHIBIDOR -1 DEL ACTIVADOR DE PLASMINÓGENO (PAI-1), SU PAPEL EN LOS FENÓMENOS TROMBÓTICOS Y LA POSIBILIDAD DE BLOQUEARLO.  // Informe Medico;may2010, Vol. 12 Issue 5, p285 

    No abstract available.

  • A Case of Brucella Endocarditis in Association with Subclavian Artery Thrombosis. Colomba, Claudia; Siracusa, Lucia; Rubino, Raffaella; Trizzino, Marcello; Scarlata, Francesco; Imburgia, Claudia; Titone, Lucina // Case Reports in Infectious Diseases;2012, p1 

    Brucellosis is a common zoonosis, endemic in Mediterranean countries, and caused by bacteria of Brucella genus. Brucellosis is a systemic infection and the clinical presentation varies widely from asymptomatic and mild to severe disease. Cardiovascular complications are extremely rare. We...

  • Antithrombotic therapy in cancer. Kakkar, A K; Williamson, R C N // BMJ: British Medical Journal (International Edition);06/12/99, Vol. 318 Issue 7198, p1571 

    Editorial. Provides information on the treatment of thrombosis. Risk factors of the disease; Thrombotic risk of chemotherapy; Details on intravenous unfractionated heparin regimen.

  • More information emerging on NSAIDs' potential cardiovascular risks. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;3/15/2014, Vol. 71 Issue 6, p442 

    The article provides information on the increased evidence on the potential cardiovascular risks of nonsteroidal antiinflammatory drugs (NSAID). Topics discussed include the evidence obtained from advisers questioned by the U.S. Food and Drug Administration (FDA), evidence of the lower risk of...

  • Personalized management of essential thrombocythemia-application of recent evidence to clinical practice. Tefferi, A; Barbui, T // Leukemia (08876924);Aug2013, Vol. 27 Issue 8, p1617 

    The World Health Organization (WHO) classification system has recently strengthened the diagnostic criteria for essential thrombocythemia (ET) by lowering the threshold platelet count, underscoring its morphological distinction from early/prefibrotic myelofibrosis (MF) and incorporating...

  • The relationship between Lp-PLA2 level and severity coronary artery disease in patient with acute coronary syndrome. Gunay, Tufan; Demir, Mehmet; Orhan, Ahmet Lutfu; Eren, Mehmet // HealthMed;2012, Vol. 6 Issue 12, p4106 

    Background: Inflammation is one of the factors playing role in acute coronary syndrome (ACS). Many independent evaluation studies have been published verifying the role of inflammation in atherogenesis and supporting the opinion that lipoprotein-associated phospholipase A2 (Lp-PLA2) is a...

  • Thrombin generation in ankylosing spondylitis. Prati, Clément; Racadot, Evelyne; Cedoz, Jean-Pierre; Wendling, Daniel // Clinical Rheumatology;Apr2011, Vol. 30 Issue 4, p511 

    nkylosing spondylitis (AS) is a chronic inflammatory disease associated with an increase in cardiovascular risk. Thrombin generation is associated with the risk of thrombosis, and the endogenous thrombin potential (ETP) has been proposed as a parameter for plasma-based hypercoagulability. The...

  • Complete aortoiliac thrombosis in a patient during pretransplant cardiovascular evaluation. Mesquita, M.; Demulder, A.; Nazeri, A.; Bergmann, P. // Indian Journal of Nephrology;May/Jun2012, Vol. 22 Issue 3, p226 

    The article presents a case study of a 49-year-old man who had a clinical history of multiple arterial thrombotic events and was on long‑term oral anticoagulation because of positive antiphospholipid antibodies. Suffering from progressive renal failure, his abdominal x-ray demonstrated...

  • The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome. Rupa-Matysek, Joanna; Gil, Lidia; Wojtasińska, Ewelina; Ciepłuch, Katarzyna; Lewandowska, Maria; Komarnicki, Mieczysław // Rheumatology International;Nov2014, Vol. 34 Issue 11, p1599 

    Increased mean platelet volume (MPV) is associated with platelet reactivity and is a predictor of cardiovascular risk and unprovoked venous thromboembolism. The aim of our study was to evaluate MPV in patients with confirmed antiphospholipid antibody syndrome (APS) and to identify the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics